Cory S. Wagg

4.3k total citations · 2 hit papers
60 papers, 3.3k citations indexed

About

Cory S. Wagg is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Cory S. Wagg has authored 60 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cardiology and Cardiovascular Medicine, 29 papers in Molecular Biology and 27 papers in Physiology. Recurrent topics in Cory S. Wagg's work include Cardiovascular Function and Risk Factors (33 papers), Adipose Tissue and Metabolism (22 papers) and Mitochondrial Function and Pathology (10 papers). Cory S. Wagg is often cited by papers focused on Cardiovascular Function and Risk Factors (33 papers), Adipose Tissue and Metabolism (22 papers) and Mitochondrial Function and Pathology (10 papers). Cory S. Wagg collaborates with scholars based in Canada, United States and Iraq. Cory S. Wagg's co-authors include Gary D. Lopaschuk, John R. Ussher, Liyan Zhang, Gavin Y. Oudit, Jagdip S. Jaswal, Jason R.B. Dyck, Osama Abo Alrob, Liyan Zhang, Jun Mori and Kim L. Ho and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Cory S. Wagg

58 papers receiving 3.3k citations

Hit Papers

Empagliflozin Increases Cardiac Energy Production in Diab... 2018 2026 2020 2023 2018 2024 50 100 150 200 250

Peers

Cory S. Wagg
Comparison fields: 5 of 87
  • Molecular Biology 1.7k
  • Cardiology and Cardiovascular Medicine 1.7k
  • Physiology 1.1k
  • Endocrinology, Diabetes and Metabolism 706
  • Surgery 470
Jagdip S. Jaswal Canada
Ivan Luptak United States
Vlad G. Zaha United States
Ellen Aasum Norway
M. Rosca United States
Christian Riehle United States
Gary D. Lopaschuk Canada
Gorka San José Spain
Sandra Sena United States
Javier Beaumont Spain
Jagdip S. Jaswal Canada View profile →
Citations per field, relative to Cory S. Wagg
Cory S. Wagg · 1×
Citations per year, relative to Cory S. Wagg
Cory S. Wagg · 1×

Countries citing papers authored by Cory S. Wagg

Since Specialization
Citations

This map shows the geographic impact of Cory S. Wagg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cory S. Wagg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cory S. Wagg more than expected).

Fields of papers citing papers by Cory S. Wagg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cory S. Wagg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cory S. Wagg. The network helps show where Cory S. Wagg may publish in the future.

Co-authorship network of co-authors of Cory S. Wagg

This figure shows the co-authorship network connecting the top 25 collaborators of Cory S. Wagg. A scholar is included among the top collaborators of Cory S. Wagg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cory S. Wagg. Cory S. Wagg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Pharmacological Inhibition of Succinyl Coenzyme A:3‐Ketoacid Coenzyme A Transferase Alleviates the Progression of Diabetic Cardiomyopathy Journal of the American Heart Association Amanda A. Greenwell, Cory S. Wagg et al. 5
2 Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction breakdown → Cardiovascular Research Qiuyu Sun, Cory S. Wagg et al. 48
3 Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation Metabolism Simran Pherwani, David Connolly et al. 8
4 Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice Basic Research in Cardiology Qiuyu Sun, Cory S. Wagg et al. 8
5 Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction Journal of Pharmacology and Experimental Therapeutics Qiuyu Sun, Cory S. Wagg et al. 11
6 Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart Metabolism Golam M. Uddin, Qutuba G. Karwi et al. 30
7 Insulin directly stimulates mitochondrial glucose oxidation in the heart Cardiovascular Diabetology Qutuba G. Karwi, Cory S. Wagg et al. 41
8 Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction Cardiovascular Diabetology Qutuba G. Karwi, Liyan Zhang et al. 68
9 Acetylation contributes to hypertrophy-caused maturational delay of cardiac energy metabolism JCI Insight Arata Fukushima, Liyan Zhang et al. 27
10 Empagliflozin Increases Cardiac Energy Production in Diabetes breakdown → JACC Basic to Translational Science Subodh Verma, Sonia Rawat et al. 293
11 Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling Cardiovascular Research Osama Abo Alrob, Sowndramalingam Sankaralingam et al. 176
12 Treatment with the 3-Ketoacyl-CoA Thiolase Inhibitor Trimetazidine Does Not Exacerbate Whole-Body Insulin Resistance in Obese Mice Journal of Pharmacology and Experimental Therapeutics John R. Ussher, Wendy Keung et al. 18
13 Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1 Journal of Thoracic and Cardiovascular Surgery Krishna K. Singh, Praphulla Chandra Shukla et al. 22
14 Failing mouse hearts utilize energy inefficiently and benefit from improved coupling of glycolysis and glucose oxidation Cardiovascular Research John R. Ussher, Wei Wang et al. 83
15 Activating cardiac E2F1 induces up‐regulation of pyruvate dehydrogenase kinase 4 in mice on a short term of high fat feeding FEBS Letters Liyan Zhang, Jun Mori et al. 18
16 Chronic Inhibition of Pyruvate Dehydrogenase in Heart Triggers an Adaptive Metabolic Response Journal of Biological Chemistry Kari T. Chambers, Teresa C. Leone et al. 87
17 Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation Cardiovascular Research Liyan Zhang, John R. Ussher et al. 103
18 Elevated levels of activated NHE1 protect the myocardium and improve metabolism following ischemia/reperfusion injury Journal of Molecular and Cellular Cardiology Fatima Mraiche, Cory S. Wagg et al. 16
19 Role of the atypical protein kinase Cζ in regulation of 5′-AMP-activated protein kinase in cardiac and skeletal muscle American Journal of Physiology-Endocrinology and Metabolism John R. Ussher, Jagdip S. Jaswal et al. 19
20 α-Lipoic acid increases cardiac glucose oxidation independent of AMP-activated protein kinase in isolated working rat hearts Basic Research in Cardiology Arzu Onay-Beşi̇kçi̇, Cory S. Wagg et al. 9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026